Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Calcium phosphate cement" patented technology

Calcium phosphate cement (CPC) is a breakthrough of biomaterials aimed for the reconstruction of bone defect. Upon mixing its powder phase with its liquid phase, it sets to form apatite or dicalcium phosphate dihydrate.

Preparation method of high-strength calcium silicon-phosphate bone cement as well as product and application of high-strength calcium silicon-phosphate bone cement

The invention relates to a method in the technical field of biomedical materials, in particular to a preparation method of high-strength calcium silicon-phosphate bone cement as well as a product and application of the high-strength calcium silicon-phosphate bone cement. A silicon element is introduced on the basis of calcium phosphate bone cement, the preparation method of the calcium silicon-phosphate bone cement is provided, calcium silicon-phosphate is prepared through a high-temperature calcination method and compounded with alpha-TCP, then the calcium silicon-phosphate compounded hydroxyapatite bone cement is prepared through a hydration reaction, the crystalline phase structure and solubility of the material are optimized, and the calcium silicon-phosphate bone cement is prepared. The degradation rate and the new bone growth rate are more synchronous, and finally, the material is completely replaced by new bone tissues; compared with traditional calcium phosphate cement, mechanical properties such as compressive strength of the silicon-calcium phosphate bone cement are improved, and clinical requirements of non-bearing or low-bearing parts can be better met. The preparation method is simple and convenient, adopts simple raw materials, is suitable for mass production, and has a wide clinical application prospect.
Owner:SHANGHAI NAT ENG RES CENT FORNANOTECH +1

Method for producing microorganism carrier

This method for producing a microorganism carrier comprises: a slurry preparation step for preparing a slurry containing a cement component that contains calcium phosphate and a microorganism-containing solution that contains active microorganisms, which are active, and water; and a curing step for curing the slurry. The active microorganisms may be one or more selected from fungi, bacteria, and archaea. The amount of the active microorganisms contained in the microorganism-containing solution may be 1.0 × 105 cells / mL to 1.0 × 109 cells / mL.
Owner:TOHOKU UNIV

Drug-loaded microsphere-modified porous calcium phosphate cement and its preparation method and repair material

This invention relates to the field of bone repair technology, specifically to drug-loaded microsphere-modified porous calcium phosphate bone cement, its preparation method, and repair material. The solid phase of the porous calcium phosphate bone cement consists of a porous calcium phosphate bone cement matrix and drug-loaded microspheres dispersed therein. The porous calcium phosphate bone cement matrix has a three-dimensional interconnected pore structure, and the drug-loaded microspheres have a core-shell structure, with the outer shell being a biodegradable material and the core being a osteoinducing factor. This porous calcium phosphate bone cement utilizes porous CPC to provide space for bone integration, and the drug-loaded microspheres achieve long-term controlled release of the osteoinducing factor, achieving efficient bone defect repair through an integrated "bone conduction-bone induction-bone integration" process.
Owner:CHANGCHUN SINOBIOMATERIALS CO LTD

Bone repair composite material with gelatin microspheres capable of releasing drugs and preparation method thereof

The application discloses a bone repair composite material with gelatin microspheres capable of releasing drugs and a preparation method thereof, and comprises the following steps: preparing a microfluid channel by 3D printing and performing surface modification on the microfluid channel by adopting tetramethyldisiloxane; adding gelatin into a phosphate buffer solution, dissolving, then adding antibiotics, stirring uniformly, and obtaining an aqueous phase; uniformly mixing mineral oil and a dispersing agent to obtain an oil phase; simultaneously feeding the aqueous phase and the oil phase into the modified microfluid channel to obtain drug-loaded gelatin microspheres; adding a crosslinking agent into the drug-loaded gelatin microspheres, freeze-drying, obtaining a drug-encapsulated gelatin drug packaging micro-particle carrier, and then mixing the drug-encapsulated gelatin drug packaging micro-particle carrier with calcium phosphate cement, and solidifying.
Owner:XI AN JIAOTONG UNIV

Bone cement loaded with bisphosphate modified nano iron oxide diagnosis and treatment integrated probe as well as preparation method and application of bone cement

PendingCN121731555AProsthesisP phosphateBone targeting
The invention discloses bone cement loaded with a bisphosphate modified nano iron oxide diagnosis and treatment integrated probe as well as a preparation method and application of the bone cement. The bone cement is composed of a calcium phosphate bone cement matrix and diagnosis and treatment integrated probes uniformly dispersed in the calcium phosphate bone cement matrix. The probe takes superparamagnetic ferroferric oxide nanoparticles as a core, a bone targeting function is realized by connecting diphosphate molecules through surface coordination, and the outer layer is coated with a liposome membrane to enhance biocompatibility and prolong cycle time and is used as a drug carrier. The bone cement disclosed by the invention has excellent mechanical properties, biological activity and multi-mode diagnosis and treatment functions; on one hand, the bone cement can be used as a bone defect filling material to provide mechanical support and promote bone regeneration; and on the other hand, the nano iron oxide in the probe can be used as a magnetic resonance imaging contrast agent, the diphosphate modification endows the probe with natural targeting ability to bone tissues and a curative effect of inhibiting osteoclasts, the liposome encapsulation realizes long-acting slow release and controllable release of the drug, and the systemic toxicity is reduced.
Owner:SHANGHAI NAT ENG RES CENT FORNANOTECH +1